The antiparasitic drug atovaquone enhanced the phosphorylation of eIF2α, increased ATF4 protein levels and transcription of ATF4 target genes, and inhibited mitochondrial OXPHOS, which resulted in growth arrest and apoptosis of AML patient cells (87). The gene discussed is EIF2A; the disease is acute myeloid leukemia.